Newsroom | 4047 results

Sorted by: Latest

Dental
-

Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations

BARCELONA, Spain & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East...
-

Align Technology to Speak at Upcoming Financial Conferences

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Te...
-

Colgate-Palmolive Webcasts Fireside Chat at the dbAccess Global Consumer Conference

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant and Executive Vice President, M&A and Special Projects, John Faucher will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on Wednesday, June 3, 2026 at 8:45 am ET. Investors may access a live webcast of this fireside chat on Colgate’s website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the web...
-

ProEncia Biotechnology Closes Pre-Seed Funding to Advance Next-Gen, Patent-Pending Periodontal Disease Treatment

MINNEAPOLIS--(BUSINESS WIRE)--Twin Cities-based ProEncia Biotechnology, a biopharma startup, today announced the company has closed significant pre-seed funding to advance its next-generation periodontal disease treatment. Funding will be applied to further develop, commercialize, and license a pipeline of novel, non-invasive periodontal care products designed for patients suffering from periodontal disease at all stages of severity. “According to the World Health Organization, more than one bi...
-

Texas Cancer Institute Adopts Kallisio’s Patient-Specific Stentra™ Oral Immobilization Solution as Standard-of-Care Following Successful Pilot

BALTIMORE--(BUSINESS WIRE)--Kallisio announces TCI in Austin, Texas has adopted patient-specific Stentra™ for improved head and neck cancer radiation therapy....
-

Smile Partners USA Selects Denticon by Planet DDS to Modernize Operations and Support Scalable Growth Across 120 Locations

IRVINE, Calif.--(BUSINESS WIRE)--Smile Partners USA, a multi-state dental support organization (DSO) with 120 locations across Alabama, Colorado, Georgia, Illinois, Michigan, and Ohio, has selected Denticon by Planet DDS as its enterprise practice management platform. At the heart of Smile Partners USA is a straightforward belief: Dental care means more than treatments. It is about consistent support from familiar faces who know each patient’s smile best. Across its network, the organization ha...
-

Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth

AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the global leader in dental technology, today announced the release of its 2026 Catalyst Index, the fifth edition of its annual benchmarking report analyzing performance across tens of thousands of DSOs, multi-location organizations, and private practices. This year’s data points to a clear and urgent shift for the industry: in a slower economy, growth is no longer determined by scale or efficiency alone; it is driven by clinical execution...
-

Riassunto: Oral‑B annuncia The Big Rethink 2026 e il lancio di uno dei più vasti studi sulla salute orale dedicati alle persone con disabilità

BARCELLONA, Spagna--(BUSINESS WIRE)--Oral‑B ha annunciato oggi The Big Rethink 2026, l’evoluzione successiva del suo programma principale di inclusione per l’igiene orale, sviluppato in collaborazione con la International Association for Disability and Oral Health (iADH). La nuova fase introduce Project Steady, uno dei più vasti studi basato su dati reali in Europa, che esplora le esperienze di igiene orale tra le persone con disabilità, i loro caregiver e i professionisti del settore odontoiat...
-

Samenvatting: Oral‑B kondigt The Big Rethink 2026 aan en lanceert hiermee een van Europa’s grootste studies van de mondgezondheid gericht op mensen met een handicap

BARCELONA, Spanje--(BUSINESS WIRE)--Oral‑B kondigt vandaag The Big Rethink 2026 aan, de volgende ontwikkeling van zijn vlaggenschipinclusieprogramma voor de mondgezondheid, ontwikkeld in samenwerking met de International Association for Disability and Oral Health (iADH). De nieuwe fase introduceert Project Steady, een van de grootste studies van Europa uitgevoerd in de echte wereld, waarin onderzoek wordt gedaan naar de ervaringen van mondverzorging bij mensen met een handicap, hun zorgverlener...
-

Oral‑B przedstawia “The Big Rethink 2026”, rozpoczynając jedno z największych w Europie badań dotyczących zdrowia jamy ustnej osób z niepełnosprawnościami

BARCELONA, Hiszpania--(BUSINESS WIRE)--Marka Oral‑B przedstawiła „The Big Rethink 2026”, kolejną odsłonę swojego sztandarowego programu na rzecz inkluzywnej higieny jamy ustnej opracowanego we współpracy z Międzynarodowym Stowarzyszeniem na Rzecz Osób z Niepełnosprawnościami i Zdrowia Jamy Ustnej – International Association for Disability and Oral Health (iADH). Wraz z tym nowym etapem debiutuje Projekt “Steady”, jedno z największych w Europie badań prowadzonych w rzeczywistych warunkach, które...